Abstract
The virus of human poliomyelitis has been demonstrated in excretions before onset of the disease, during the disease, and in convalescence. It may be confused with different viruses likely to be found in the same sources in clinical conditions resembling poliomyelitis.
Immunologic differences between strains of poliomyelitis virus have been detected so that three types are now evident. The distribution of these types and their importance as causes of epidemics are not known. This multiplicity of immunologic types is an important factor in considering immunization of humans. Commercial manufacture of vaccines faces many technical problems.
Recently the Coxsackie virus has been demonstrated in humans with a disease closely resembling poliomyelitis.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BODIAN D. Neutralization of three immunological types of poliomyelitis virus by human gamma globulin. Proc Soc Exp Biol Med. 1949 Oct;72(1):259–261. doi: 10.3181/00379727-72-17399. [DOI] [PubMed] [Google Scholar]
- CASALS J., OLITSKY R. K., MURPHY L. C. Hemagglutination and complement fixation with type I and II Albany strains of Coxsackie virus. Proc Soc Exp Biol Med. 1949 Dec;72(3):636–638. doi: 10.3181/00379727-72-17524. [DOI] [PubMed] [Google Scholar]
- CURNEN E. C., SHAW E. W., MELNICK J. L. Disease resembling nonparalytic poliomyelitis associated with a virus pathogenic for infant mice. J Am Med Assoc. 1949 Nov 26;141(13):894–901. doi: 10.1001/jama.1949.02910130008003. [DOI] [PubMed] [Google Scholar]
- HOWITT B. F., BENEFIELD U. R. Use of complement fixation in the differentiation of strains of Coxsackie virus. Proc Soc Exp Biol Med. 1950 Jan;73(1):90–92. doi: 10.3181/00379727-73-17586. [DOI] [PubMed] [Google Scholar]
- Loring H. S., Schwerdt C. E., Lawrence N., Anderson J. C. Preparation of Formaldehyde-inactivated Poliomyelitis Virus and Its Use as an Immunizing Agent in Cotton Rats. Science. 1947 Aug 1;106(2744):104–105. doi: 10.1126/science.106.2744.104. [DOI] [PubMed] [Google Scholar]
- MELNICK J. L., LEDINKO N. Ohio strains of a virus pathogenic for infant mice, Coxsackie group; simultaneous occurrence with poliomyelitis virus in patients with summer grippe. J Exp Med. 1950 Feb;91(2):185–195. doi: 10.1084/jem.91.2.185. [DOI] [PMC free article] [PubMed] [Google Scholar]
- MORGAN I. M. Distribution of antibody to poliomyelitis in vaccinated and paralytic monkeys. Fed Proc. 1949 Sep;8(3):618–621. [PubMed] [Google Scholar]
- QUIGLEY J. J. Ultrafiltration and ultracentrifugation studies of Coxsackie virus. Proc Soc Exp Biol Med. 1949 Nov;72(2):434–434. doi: 10.3181/00379727-72-17459. [DOI] [PubMed] [Google Scholar]
- SABIN A. B., STEIGMAN A. J. Studies of local antibody formation in the nervous system of paralyzed, poliomyelitis convalescent monkeys. J Immunol. 1949 Oct;63(2):211–218. [PubMed] [Google Scholar]
- SICKLES G. M., DALLDORF G. Serologic differences among strains of the Coxsackie group of viruses. Proc Soc Exp Biol Med. 1949 Oct;72(1):30–30. doi: 10.3181/00379727-72-17321. [DOI] [PubMed] [Google Scholar]
- WARREN J., WEIL M. L. Purification of certain viruses by use of protamine sulfate. Proc Soc Exp Biol Med. 1949 Dec;72(3):662–664. doi: 10.3181/00379727-72-17535. [DOI] [PubMed] [Google Scholar]